81 assets in Primary Mediastinal Large B-Cell Lymphoma

Therapeutic assets addressing Primary Mediastinal Large B-Cell Lymphoma, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
CD47/SIRPA-BLOCKING AGENT ALX148 Primary Mediastinal Large B-Cell Lymphoma	M.D. Anderson Cancer Center	P1/2	CCC (48)
mdx2003 Primary Mediastinal Large B-Cell Lymphoma	ModeX Therapeutics, An OPKO Health Company	P1/2	CCC (48)
Ibrutinib Primary Mediastinal Large B-Cell Lymphoma	Yazeed Sawalha	P1/2	CC (47)
Interleukin 18 (Recombinant Human Mutein Clone St-067) Primary Mediastinal Large B-Cell Lymphoma	Fred Hutchinson Cancer Center	P1/2	CC (47)
1-118-Signal regulatory protein ? (human) fusion protein with immunoglobulin G4 [128-proline] (human ?4-chain C region C-terminal fragment), dimer Primary Mediastinal Large B-Cell Lymphoma	Mayo Clinic	P2	CC (45)
cd19 specific chimeric antigen receptor t cell Primary Mediastinal Large B-Cell Lymphoma	Pell Bio-Med Technology Co., Ltd.	P1/2	CC (45)
crc01 Primary Mediastinal Large B-Cell Lymphoma	Curocell Inc.	P1/2	CC (45)
tc011 Primary Mediastinal Large B-Cell Lymphoma	TICAROS Co., Ltd.	P1/2	CC (45)
Vnx-101 Primary Mediastinal Large B-Cell Lymphoma	Vironexis Biotherapeutics Inc.	P1/2	CC (45)
ace1831 Primary Mediastinal Large B-Cell Lymphoma	Acepodia Biotech, Inc.	P1	CC (44)
Immunoglobulin G1, Anti-(Human Cd Antigen Cd27) (Human Monoclonal Cdx-1127 Clone 1F5 Heavy Chain), Disulfide With Human Monoclonal Cdx-1127 Clone 1F5 .Kappa.-Chain, Dimer Primary Mediastinal Large B-Cell Lymphoma	National Cancer Institute (NCI)	P2	CC (44)
1928z1xx trac t cell Primary Mediastinal Large B-Cell Lymphoma	Memorial Sloan Kettering Cancer Center	P1	CC (43)
Adi-001 Primary Mediastinal Large B-Cell Lymphoma	Adicet Therapeutics	P1	CC (43)
c402-cd19-car Primary Mediastinal Large B-Cell Lymphoma	Shanghai Exuma Biotechnology Ltd.	P1	CC (43)
Car-Nk-Cd19 Cells Primary Mediastinal Large B-Cell Lymphoma	Second Affiliated Hospital, School of Medicine, Zhejiang University	P1	CC (43)
Gf-Cart01 Primary Mediastinal Large B-Cell Lymphoma	GenomeFrontier Therapeutics TW Co., Ltd.	P1	CC (43)
Immunoglobulin G4, Anti-(Human Colony-Stimulating Factor 1 Receptor) (Human-Rattus Norvegicus Monoclonal Sndx-6352 .Gamma.4-Chain), Disulfide With Human-Rattus Norvegicus Monoclonal Sndx-6352 .Kappa.-Chain, Dimer Primary Mediastinal Large B-Cell Lymphoma	Northside Hospital, Inc.	P1	CC (43)
L-Methionyl-Interleukin 15 (Human, Non-Glycosylated), Produced In Escherichia Coli, Substituted On An Average Of One Site Among N2 Of Met1 And/Or N6 Of Lysyl Residues With 4-(.Alpha.-Methylpoly(Oxyethylene)-.Omega.-Oxy)Butanoyl Groups (~40 Kda Each) Primary Mediastinal Large B-Cell Lymphoma	Fred Hutchinson Cancer Center	P1	CC (43)
Vorinostat Primary Mediastinal Large B-Cell Lymphoma	City of Hope Medical Center	P1	CC (43)
Wztl002-1 Primary Mediastinal Large B-Cell Lymphoma	Malaghan Institute of Medical Research	P1	CC (43)
cd19.20.22 car t cells Primary Mediastinal Large B-Cell Lymphoma	University of Maryland, Baltimore	P1	CC (41)
cd30.car-t Primary Mediastinal Large B-Cell Lymphoma	Tessa Therapeutics	P1	CC (41)
cd79b-19 car t cells Primary Mediastinal Large B-Cell Lymphoma	Marcela V. Maus, M.D.,Ph.D.	P1	CC (41)
Clic-2201 Primary Mediastinal Large B-Cell Lymphoma	British Columbia Cancer Agency	P1	CC (41)
P-Cd19Cd20-Allo1 Primary Mediastinal Large B-Cell Lymphoma	Poseida Therapeutics, Inc.	P1	CC (41)
Rimiducid Primary Mediastinal Large B-Cell Lymphoma	Poseida Therapeutics, Inc.	P1	CC (41)
Sgr-1505 Primary Mediastinal Large B-Cell Lymphoma	Schrödinger, Inc.	P1	CC (41)
Synkir-310 Primary Mediastinal Large B-Cell Lymphoma	Verismo Therapeutics	P1	CC (41)
Allogeneic Natural Killer Cells Primary Mediastinal Large B-Cell Lymphoma	Paolo Caimi, MD	P1	CC (40)
Anti Cd30 Car-T Cell Primary Mediastinal Large B-Cell Lymphoma	Zhejiang University	Early P1	C (39)

Showing 51 to 81 of 81 assets

PreviousPage 2 of 2Next